B. Richards

1.8k total citations
38 papers, 933 citations indexed

About

B. Richards is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, B. Richards has authored 38 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in B. Richards's work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (10 papers) and Prostate Cancer Treatment and Research (6 papers). B. Richards is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (10 papers) and Prostate Cancer Treatment and Research (6 papers). B. Richards collaborates with scholars based in United Kingdom, United States and Belgium. B. Richards's co-authors include M. R. G. Robinson, Richard Price, N. Dance, W. R. Cattell, D.W.W. Newling, Philip H. Smith, J. R. G. BASTABLE, M. De Pauw, R.W. Glashan and J. G. B. Russell and has published in prestigious journals such as The Journal of Urology, European Urology and European Journal of Cancer.

In The Last Decade

B. Richards

38 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Richards United Kingdom 18 356 298 169 136 130 38 933
J. Ramon Israel 20 238 0.7× 393 1.3× 145 0.9× 281 2.1× 131 1.0× 51 914
R.A. Medina López Spain 18 245 0.7× 394 1.3× 208 1.2× 113 0.8× 244 1.9× 143 996
David L. Nicol Australia 17 592 1.7× 462 1.6× 314 1.9× 182 1.3× 171 1.3× 32 1.7k
Abdolrasoul Mehrsai Iran 18 333 0.9× 263 0.9× 110 0.7× 217 1.6× 173 1.3× 51 1.1k
Antonio Manenti Italy 14 429 1.2× 172 0.6× 199 1.2× 51 0.4× 203 1.6× 100 931
Steinar Karlsen Norway 14 225 0.6× 426 1.4× 47 0.3× 72 0.5× 104 0.8× 30 769
Hanzhang Wang United States 17 366 1.0× 384 1.3× 191 1.1× 223 1.6× 309 2.4× 88 1.2k
Teppei Okamoto Japan 16 209 0.6× 256 0.9× 138 0.8× 116 0.9× 102 0.8× 93 805
Chaidir Arif Mochtar Indonesia 15 299 0.8× 411 1.4× 86 0.5× 254 1.9× 128 1.0× 78 868
Taek Won Kang South Korea 21 504 1.4× 366 1.2× 122 0.7× 289 2.1× 361 2.8× 111 1.3k

Countries citing papers authored by B. Richards

Since Specialization
Citations

This map shows the geographic impact of B. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Richards more than expected).

Fields of papers citing papers by B. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Richards. The network helps show where B. Richards may publish in the future.

Co-authorship network of co-authors of B. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of B. Richards. A scholar is included among the top collaborators of B. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Richards. B. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fosså, Sophie D., Neil K. Aaronson, L. Denis, et al.. (1996). The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853. European Journal of Cancer. 32(1). 72–77. 64 indexed citations
2.
Roberts, J.T., Sophie D. Fosså, B. Richards, et al.. (1991). Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the Bladder. British Journal of Urology. 68(2). 162–168. 20 indexed citations
3.
Richards, B., Malin Parmar, C. K. Anderson, et al.. (1991). Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer. British Journal of Urology. 67(4). 369–375. 38 indexed citations
4.
Hetherington, John, E.H. Cooper, D.W.W. Newling, et al.. (1986). Biochemical Monitoring of Carcinoma of Prostate Treated with an LH‐RH Analogue (Zoladex). British Journal of Urology. 58(6). 676–682. 26 indexed citations
6.
Somerville, Jason, Don Newling, B. Richards, M. R. G. Robinson, & Philip H. Smith. (1985). Mitomycin C in Superficial Bladder Cancer: 24‐month Follow‐up. British Journal of Urology. 57(6). 686–689. 11 indexed citations
7.
Hall, R., D.W.W. Newling, Peter Ramsden, et al.. (1984). Treatment of Invasive Bladder Cancer by Local Resection and High Dose Methotrexate. British Journal of Urology. 56(6). 668–672. 55 indexed citations
8.
Cartwright, Reed A., Reza Adib, R.W. Glashan, et al.. (1983). Ten genetic polymorphisms in bladder cancer.. Journal of Medical Genetics. 20(2). 112–116. 2 indexed citations
9.
Smith, Philip H., J. A. Child, J.H. Mulder, et al.. (1983). Cooperative studies of systemic chemotherapy. Cancer Chemotherapy and Pharmacology. 11(S1). S25–S31. 7 indexed citations
10.
Harrison, Gail S., et al.. (1983). A Phase II Study of lntravesical Mitomycin C in the Treatment of Superficial Bladder Cancer. British Journal of Urology. 55(6). 676–679. 34 indexed citations
11.
Richards, B., J. R. G. BASTABLE, Laurence S. Freedman, et al.. (1983). Adjuvant Chemotherapy with Doxorubicin (Adriamycin) and 5–Fluorouracil in T3, NX, MO Bladder Cancer Treated with Radiotherapy. British Journal of Urology. 55(4). 386–391. 50 indexed citations
12.
Richards, B., A. Akdaş, P J Corbett, et al.. (1979). Adjuvant Chemotherapy Following Radical Radiotherapy in T3 Bladder Carcinoma. Recent results in cancer research. 68. 334–337. 5 indexed citations
13.
Richards, B., et al.. (1979). Complications of Antifibrinolysis Therapy after Prostatectomy. British Journal of Urology. 51(3). 211–212. 18 indexed citations
14.
Richards, B. & E. M. Cooke. (1979). Faecal and Introital Bacteria and Urinary Tract Infection. British Journal of Urology. 51(4). 317–320. 2 indexed citations
15.
Robinson, M. R. G., et al.. (1977). Intravesical Epodyl in the Management of Bladder Tumors: Combined Experience of the Yorkshire Urological Cancer Research Group. The Journal of Urology. 118(6). 972–973. 20 indexed citations
16.
Richards, B., et al.. (1977). Bacteriuria after Out‐patient Cystoscopy. British Journal of Urology. 49(6). 561–564. 15 indexed citations
17.
BASTABLE, J. R. G., et al.. (1977). Continuous Irrigation of the Bladder after Prostatectomy: Its Effect on Post‐Prostatyectomy Infection. British Journal of Urology. 49(7). 689–693. 29 indexed citations
18.
Richards, B., et al.. (1977). The Rate of Urine Production and the Isotope Renogram. British Journal of Urology. 49(5). 355–360. 2 indexed citations
19.
BASTABLE, J. R. G., et al.. (1973). Estimation of Residual Urine Volume with 131 I‐Hippuran. British Journal of Urology. 45(4). 408–414. 2 indexed citations
20.
Richards, B., et al.. (1970). EXTRA‐CORPOREAL PERFUSION ON AN ARTERIOVENOUS SHUNT AS A METHOD OF FUNCTIONAL ASSESSMENT OF PRESERVED KIDNEYS. British Journal of Urology. 42(2). 129–135. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026